Zometa Plus Quadramet, Metastron For Bone Tumors Subject Of NCI-Funded Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Study will evaluate whether a radionucleotide plus a bisphosphonate can treat metastases caused by lung, breast, prostate cancer.
You may also be interested in...
Liquid Tamoxifen To Be Launched By Cytogen In Third Quarter
Cytogen signs an exclusive distribution agreement with manufacturer Savient.
Novartis Institute For Tropical Diseases Could Have TB Drug In Clinic By Late 2007
Singapore-based institute is also looking at dengue fever and malaria, exec says in interview with “The Pink Sheet” DAILY.
Lilly To Settle Additional Zyprexa Liability Cases, Will Pay Up To $500 Million
Lilly will pay up to $500 million to settle the "vast majority" of claims alleging that the company failed to adequately warn patients of risks associated with the atypical antipsychotic Zyprexa (olanzapine), the firm announced Jan. 4